Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience
Daniele Cattaneo, Cristina Bucelli, Francesca Cavallaro, Dario Consonni, Alessandra Iurlo
Abstract
The SARS-CoV-2 coronavirus infection causing the coronavirus disease 2019 (COVID-19) is a highly contagious and life-threatening disease critically associated with a high rate of respiratory failure, thrombo-hemorrhagic complications, and death, mainly due to an abnormal inflammatory response [ 1 ].
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)HematologyRuxolitinibCenter (category theory)OncologyImmunologyInternal medicineVirologyBone marrowMyelofibrosisCrystallographyInfectious disease (medical specialty)DiseaseOutbreakChemistryMyeloproliferative Neoplasms: Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsEosinophilic Disorders and Syndromes